Jaguar Health (JAGX) Total Current Liabilities (2014 - 2026)
Jaguar Health (JAGX) reported Total Current Liabilities of $40.7 million for Q1 2026, up 44.24% year-over-year from $28.2 million in Q1 2025, and little changed quarter-over-quarter from $40.7 million in Q4 2025.
Jaguar Health (JAGX) Total Current Liabilities (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Total Current Liabilities data on file, last reported at $40.7 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $40.7 million, up 44.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.7 million (up 44.24% YoY), and the FY2025 annual result was $40.7 million, up 106.32% from the prior year.
- Total Current Liabilities was little changed at $40.7 million in Q1 2026 per JAGX's latest filing, from $40.7 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $40.7 million in Q1 2026 and troughed at $12.5 million in Q3 2023.
- A 5-year average of $25.7 million and a median of $26.9 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities soared 125.45% in 2022, then slumped 53.9% in 2023.
- A 5-year view of Total Current Liabilities shows it stood at $30.3 million in 2022, then tumbled by 53.9% to $14.0 million in 2023, then jumped by 40.87% to $19.7 million in 2024, then surged by 106.32% to $40.7 million in 2025, then advanced by 0.08% to $40.7 million in 2026.
- Business Quant data shows JAGX's Total Current Liabilities at $40.7 million in Q1 2026, $40.7 million in Q4 2025, and $36.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 72.86 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 40.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.69 Mn |
| Dec 31, 2025 | 40.65 Mn |
| Sep 30, 2025 | 36.12 Mn |
| Jun 30, 2025 | 29.22 Mn |
| Mar 31, 2025 | 28.21 Mn |
| Dec 31, 2024 | 19.70 Mn |
| Sep 30, 2024 | 19.87 Mn |
| Jun 30, 2024 | 19.13 Mn |
| Mar 31, 2024 | 17.81 Mn |
| Dec 31, 2023 | 13.99 Mn |
| Sep 30, 2023 | 12.46 Mn |
| Jun 30, 2023 | 29.00 Mn |
| Mar 31, 2023 | 31.10 Mn |
| Dec 31, 2022 | 30.34 Mn |
| Sep 30, 2022 | 26.94 Mn |
| Jun 30, 2022 | 22.90 Mn |
| Mar 31, 2022 | 19.09 Mn |
| Dec 31, 2021 | 15.47 Mn |
| Sep 30, 2021 | 11.95 Mn |
| Jun 30, 2021 | 12.65 Mn |